ANKYLOSING SPONDYLITIS

This adverse event was reported 13193 times

These drugs are most commonly taken by patients reporting ANKYLOSING SPONDYLITIS:

# Drug Count
0 ADALIMUMAB 3383
1 ETANERCEPT 2504
2 METHOTREXATE SODIUM 1889
3 METHOTREXATE 1715
4 CELECOXIB 1248
5 NAPROXEN SODIUM 1200
6 INFLIXIMAB 1187
7 NAPROXEN 1147
8 DICLOFENAC SODIUM 1129
9 DICLOFENAC 952
See all common drugs associated with ANKYLOSING SPONDYLITIS

ANKYLOSING SPONDYLITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 2230 0.0598
1 Interleukin-5 Antagonist [EPC] 13 0.0189
2 Provitamin D2 Compound [EPC] 428 0.0144
3 Guanylate Cyclase-C Agonist [EPC] 18 0.0087
4 Aminosalicylate [EPC] 865 0.0086
5 Tumor Necrosis Factor Blocker [EPC] 7309 0.0073
6 Prostaglandin E1 Analog [EPC] 91 0.0055
7 Antirheumatic Agent [EPC] 535 0.0051
8 Adrenocorticotropic Hormone [EPC] 4 0.0045
9 Folate Analog Metabolic Inhibitor [EPC] 1708 0.0039
See all drug classes enriched for association with ANKYLOSING SPONDYLITIS